<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Orthop Surg Res</journal-id><journal-id journal-id-type="iso-abbrev">J Orthop Surg Res</journal-id><journal-title-group><journal-title>Journal of Orthopaedic Surgery and Research</journal-title></journal-title-group><issn pub-type="epub">1749-799X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6347785</article-id><article-id pub-id-type="publisher-id">1053</article-id><article-id pub-id-type="doi">10.1186/s13018-018-1053-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>The efficacy of fascia iliaca compartment block for pain control after total hip arthroplasty: a meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Xiao-yan</given-names></name><address><email>zhangxiaoyan090@qq.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Ma</surname><given-names>Jian-bao</given-names></name><address><email>rongshi19670719@126.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.415946.b</institution-id><institution>Department of Anesthesiology, </institution><institution>Linyi people&#x02019;s Hospital, </institution></institution-wrap>No. 49 Yizhou Road, Lanshan District, Linyi, 276003 Shandong China </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>14</volume><elocation-id>33</elocation-id><history><date date-type="received"><day>29</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>27</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">Fascia iliaca compartment block (FICB) provides an analgesic option for total hip arthroplasty (THA) patients. The evidence supporting FICB is still not well established. The purpose of this meta-analysis was to assess FICB for pain control in THA patients.</p></sec><sec><title>Methods</title><p id="Par2">PubMed, Embase, Cochrane Library, and Chinese Wanfang database were interrogated from their inceptions to December 15, 2018. We included randomized controlled studies reported as full text, those published as abstracts only, and unpublished data, if available. Data were independently extracted by two reviewers and synthesized using a random-effects model or fixed-effects model according to the heterogeneity.</p></sec><sec><title>Results</title><p id="Par3">A total of eight RCTs were finally included for meta-analysis. Compared with placebo, FICB could significantly reduce VAS pain scores at 1&#x02013;8&#x02009;h (WMD&#x02009;=&#x02009;&#x02212;&#x02009;0.78, 95% CI [&#x02212;&#x02009;1.01, &#x02212;&#x02009;0.56], <italic>P</italic>&#x02009;=&#x02009;0.000), 12&#x02009;h (WMD&#x02009;=&#x02009;&#x02212;&#x02009;0.69, 95% CI [&#x02212;&#x02009;1.22, &#x02212;&#x02009;0.16], <italic>P</italic>&#x02009;=&#x02009;0.011), and 24&#x02009;h (WMD&#x02009;=&#x02009;&#x02212;&#x02009;0.46, 95% CI [&#x02212;&#x02009;0.89, &#x02212;&#x02009;0.02], <italic>P</italic>&#x02009;=&#x02009;0.039). Compared with the control group, FICB could significantly decrease the occurrence of nausea and length of hospital stay (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). There was no significant difference between the VAS pain score at 48&#x02009;h and risk of fall between the FICB and the control groups (<italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05).</p></sec><sec><title>Conclusions</title><p id="Par4">FICB could be used to effectively reduce pain intensity up to 24&#x02009;h, total morphine consumption, and length of hospital stay in THA patients. Optimal strategies of FICB need to be studied in the future.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s13018-018-1053-1) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Fascia iliaca compartment block</kwd><kwd>Total hip arthroplasty</kwd><kwd>Meta-analysis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par14">Total hip arthroplasty (THA) is a well-known popular surgical procedure for hip diseases, including end-stage hip osteoarthritis and femur neck fracture [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. THA is a well-known cause of severe postoperative pain. Non-steroidal antiinflammatory drugs (NSAIDs) and morphine were commonly used for pain control in THA patients [<xref ref-type="bibr" rid="CR2">2</xref>]. These drugs were related to digestive tract side effects, and patients could not tolerate these complications [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Thus, adequate pain control after THA is crucial for early ambulation and patient satisfaction.</p><p id="Par15">Fascia iliaca compartment block (FICB) is an analgesic technique that involves injecting local anesthetic under the fascia of the iliacus muscle [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. FICB can be performed either guided by ultrasound or with a loss of resistance (LOR) technique. The evidence supporting FICB for pain control for THA patients is still not well established. Several RCTs have been published concerning FICB for THA patients. However, there was no consensus about the real efficacy of FICB in THA patients. Desmet et al. [<xref ref-type="bibr" rid="CR7">7</xref>] revealed that longitudinal suprainguinal FICB reduces postoperative morphine requirements after anterior approach THA. Perry et al. [<xref ref-type="bibr" rid="CR8">8</xref>] found that FICB has comparable pain control with psoas compartment block. The samples of published literature are limited, and the statistic power is limited. However, Aprato et al. [<xref ref-type="bibr" rid="CR9">9</xref>] revealed that intra-articular hip injection provides better pre-operatory pain management in elder patients with intracapsular hip fractures compared to the FICB.</p><p id="Par16">Therefore, we performed a meta-analysis of randomized controlled trials to compare the effect of FICB versus control on the pain intensity and morphine consumption in patients undergoing THA. We hypothesized that FICB compared with placebo is associated with decreased pain intensity in patients undergoing THA. Additionally, we assessed the efficacy and safety of FICB with respect to morphine consumption, risk of fall, and nausea.</p></sec><sec id="Sec2"><title>Materials and methods</title><p id="Par17">This meta-analysis was programed on the basis of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines [<xref ref-type="bibr" rid="CR10">10</xref>]. There was no registered protocol for this meta-analysis.</p><sec id="Sec3"><title>Search strategy</title><p id="Par18">We performed a systematic electronic search in PubMed, Embase, the Cochrane library, and Chinese Wanfang database from inception through September 1, 2018. We conducted electronic searches using exploded Medical Subject Headings (MeSH) terms and corresponding key words. The search terms used in PubMed were listed in Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>. No language restriction was applied. We also manually checked the bibliographies of previous reviews and included trials to identify other potentially eligible trials.</p></sec><sec id="Sec4"><title>Inclusion criteria</title><p id="Par19">Published RCTs meeting the following criteria were included: (1) population: adult patients and prepared for THA, (2) intervention: single administration FICB for pain control, (3) comparison: placebo or saline, and (4) &#x02265;&#x02009;1 of the following outcomes: visual analog scale (VAS) at 6&#x02013;8&#x02009;h, 12&#x02009;h, 24&#x02009;h, and 48&#x02009;h; total morphine consumption; occurrence of nausea; and occurrence of fall.</p></sec><sec id="Sec5"><title>Study selection</title><p id="Par20">After the duplicates were removed and the study selection process was completed, the titles and abstracts were scanned by two independent investigators. The relevant data were extracted by adopting a predetermined standardized procedure, which involved the first authors, year of publication, country, demographic characteristics of the participants, and the treatment regimen for each group. All data were verified for internal consistency, and controversies were settled by consensus or discussion with a third author. When inadequate information existed in the studies, contacting the first authors to obtain and clarify the relevant data were essential as specified by the standardized protocol.</p></sec><sec id="Sec6"><title>Quality assessment</title><p id="Par21">Cochrane collaboration&#x02019;s tool for assessing the risk of bias was used to evaluate methodological quality of included trials. This tool focuses on the internal validity of the trial and assessment of risk of possible bias in different phases of trial conduct. The following items were assessed: random sequence generation, allocation concealment, blinding of participants, personnel and outcome assessment, incomplete outcome measures, selective outcome reporting, and other types of bias. Each item was qualified as low risk (L), unclear risk (U), or high risk (H). All assessments were conducted by two reviewers, independent of each other. Controversies were settled by consensus or discussion with a third author.</p></sec><sec id="Sec7"><title>Data extraction</title><p id="Par22">Two authors independently extracted the information from the original studies using a standardized data abstraction list, including study characteristics (such as author, publication year, country), patient characteristics (such as number of patients, mean age, gender, and female patients), intervention details for each treatment group (intervention type, dose, drugs and regimens), and outcome measures (VAS at 6&#x02013;8&#x02009;h, 12&#x02009;h, 24&#x02009;h, 48&#x02009;h; total morphine consumption; occurrence of nausea; and occurrence of fall). Data were abstracted from the article text, tables, and graphs.</p></sec><sec id="Sec8"><title>Data synthesis and statistical methods</title><p id="Par23">In this meta-analysis, effect sizes for dichotomous outcomes were expressed as relative risk (RR) with 95% confidence interval (CI). Mean difference (MD) and 95% CI were calculated for continuous outcomes. The effect sizes were computed by a random-effects model [<xref ref-type="bibr" rid="CR11">11</xref>]. <italic>I</italic><sup>2</sup> statistic was used to estimate the heterogeneity, with values greater than 50% considered as significant heterogeneity [<xref ref-type="bibr" rid="CR12">12</xref>]. Furthermore, we applied sensitivity analyses to verify the robustness of the study results by using removing trials one by one. Egger linear regression test and funnel plots were implemented to test the publication bias when more than ten publications were included [<xref ref-type="bibr" rid="CR13">13</xref>]. <italic>P</italic> values &#x0003c;&#x02009;0.05 denoted statistically significant differences. Data analysis was conducted with Stata 12.0 (Stata Corp., College Station, TX, USA).</p></sec></sec><sec id="Sec9"><title>Results</title><sec id="Sec10"><title>Search results</title><p id="Par24">The PRISMA statement flowchart shows the process of literature screening, study selection, and reasons for exclusion (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Our initial search yielded 556 potential studies. After removing duplicates by Endnote Software (Version X7, Thompson Reuters, CA, USA) and screening the titles and abstracts, eight RCTs were included in this meta-analysis [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>Flow diagram of the study selection process</p></caption><graphic xlink:href="13018_2018_1053_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec11"><title>General characteristic</title><p id="Par25">Characteristics and demographics of the included studies were presented in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. These trials were published from 2009 to 2017. Population sizes ranged from 11 to 43, with a total of 372 patients (FICB = 186, control = 186). In the included studies, age ranged from 54 to 71.2&#x02009;years. Protocol of FICB included ropivacaine and bupivacaine combined with or no epinephrine. Dose of infiltration drugs ranged from 30 to 50&#x02009;ml. Only one study reported complication (hematoma) about FICB. Most of the included studies were performed with a relative short follow-up.<table-wrap id="Tab1"><label>Table 1</label><caption><p>General characteristic of the included studies. FICB, fascia iliaca compartment block</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Author</th><th>Country</th><th>Size (<italic>n</italic>)</th><th>Age (years)</th><th>Female (%)</th><th>Intervention</th><th>Control</th><th>Nature of study</th><th>Complications</th><th>Technique</th><th>Anesthesia</th><th>Follow-up</th></tr></thead><tbody><tr><td>Shariat 2013</td><td>USA</td><td>16/16</td><td>61.0</td><td>56.2</td><td>30&#x02009;mL 0.5% ropivacaine</td><td>Placebo</td><td>RCT</td><td>NS</td><td>Parallel</td><td>GA</td><td>NS</td></tr><tr><td>Stevens 2007</td><td>Australia</td><td>22/22</td><td>54.2</td><td>50.0</td><td>40&#x02009;mL mixture of 30&#x02009;mL of 0.5% bupivacaine with 1:200000 epinephrine and 150&#x000a0;&#x003bc;g of clonidine</td><td>Placebo</td><td>RCT</td><td>NS</td><td>Perpendicular</td><td>SA</td><td>At discharge</td></tr><tr><td>Desmet 2017</td><td>Belgium</td><td>43/42</td><td>67.5</td><td>65.4</td><td>40&#x02009;mL of ropivacaine 0.5%</td><td>Placebo</td><td>RCT</td><td>NS</td><td>Perpendicular</td><td>GA</td><td>6&#x02009;months</td></tr><tr><td>Bang 2016</td><td>Korea</td><td>11/11</td><td>81.6</td><td>85.2</td><td>40&#x02009;mL of ropivacaine 0.2% with epinephrine 5&#x02009;mg/mL</td><td>Placebo</td><td>RCT</td><td>NS</td><td>Parallel</td><td>GA</td><td>NS</td></tr><tr><td>Goitia 2009</td><td>Spanish</td><td>21/20</td><td>55.6</td><td>55.0</td><td>40&#x02009;ml of 5% bupivacaine</td><td>Placebo</td><td>RCT</td><td>NS</td><td>Parallel</td><td>NS</td><td>NS</td></tr><tr><td>Deniz 2014</td><td>Turkey</td><td>20/20</td><td>59.1</td><td>56.5</td><td>2% prilocaine, 30&#x02009;ml of 0.25% bupivacaine (1&#x02009;mg/kg)</td><td>Placebo</td><td>RCT</td><td>NS</td><td>Perpendicular</td><td>GA</td><td>3&#x02009;days</td></tr><tr><td>Cucereanu Badica 2010</td><td>Romania</td><td>30/ 32</td><td>71.0</td><td>35.4</td><td>50&#x02009;mL of ropivacaine 0.2% with epinephrine</td><td>Placebo</td><td>RCT</td><td>NS</td><td>Perpendicular</td><td>GA</td><td>NS</td></tr><tr><td>Lei 2016</td><td>China</td><td>23/23</td><td>68.7</td><td>45.2</td><td>40&#x02009;ml of 5% bupivacaine</td><td>Placebo</td><td>RCT</td><td>Hematoma (<italic>n</italic>&#x02009;=&#x02009;1)</td><td>Parallel</td><td>GA</td><td>2&#x02009;days</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec12"><title>Risk of bias</title><p id="Par26">Figures&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref> describe the risk of bias summary and risk of bias graph, respectively. Overall, two trials were categorized as being at low risk of bias, four as being unclear, and two as being at high risk of bias.<fig id="Fig2"><label>Fig. 2</label><caption><p>Risk of bias summary</p></caption><graphic xlink:href="13018_2018_1053_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Risk of bias graph</p></caption><graphic xlink:href="13018_2018_1053_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec13"><title>Results of meta-analysis</title><sec id="Sec14"><title>VAS at 1&#x02013;8&#x02009;h, 12&#x02009;h, 24&#x02009;h, and 48&#x02009;h</title><p id="Par27">The VAS pain scores after treatment for 1&#x02013;8&#x02009;h&#x02009;weeks were reported in four trials. There was a little heterogeneity between the included studies (<italic>I</italic><sup>2</sup>&#x000a0;=&#x02009;9.3%, <italic>P</italic>&#x02009;=&#x02009;0.356); fixed-effects model was adapted to analyze the results. The result revealed that that FICB was superior to control in terms of VAS pain scores after intervention for 1&#x02013;8&#x02009;h (WMD&#x02009;=&#x02009;&#x02212;&#x02009;0.78, 95% CI [&#x02212;&#x02009;1.01, &#x02212;&#x02009;0.56], <italic>P</italic>&#x02009;=&#x02009;0.000, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a). There was a large heterogeneity between the included studies for VAS pain scores after treatment for 12&#x02009;h (<italic>I</italic><sup>2</sup>&#x000a0;=&#x02009;81.7%, <italic>P</italic>&#x02009;=&#x02009;0.000, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b), 24&#x02009;h (<italic>I</italic><sup>2</sup>&#x000a0;=&#x02009;73.6%, <italic>P</italic>&#x02009;=&#x02009;0.001, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c), and 48&#x02009;h (<italic>I</italic><sup>2</sup>&#x000a0;=&#x02009;92.8%, <italic>P</italic>&#x02009;=&#x02009;0.000, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>d). Random-effects model was performed for VAS pain score at 12&#x02009;h, 24&#x02009;h, and 48&#x02009;h. Results have shown that FICB has a beneficial role in reducing VAS pain scores at 12&#x02009;h (WMD&#x02009;=&#x02009;&#x02212;&#x02009;0.69, 95% CI [&#x02212;&#x02009;1.22, &#x02212;&#x02009;0.16], <italic>P</italic>&#x02009;=&#x02009;0.011, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b) and 24&#x02009;h (WMD&#x02009;=&#x02009;&#x02212;&#x02009;0.46, 95% CI [&#x02212;&#x02009;0.89, &#x02212;&#x02009;0.02], <italic>P</italic>&#x02009;=&#x02009;0.039, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c). Pooled data found that no statistically significant difference was observed between the FICB group and the control group in terms of the VAS scores after treatment for 72&#x02009;h (WMD&#x02009;=&#x02009;&#x02212;&#x02009;0.52, 95% CI [&#x02212;&#x02009;1.31, 0.28], <italic>P</italic>&#x02009;=&#x02009;0.203, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>d).<fig id="Fig4"><label>Fig. 4</label><caption><p>Forest plot for the comparison of VAS at 1&#x02013;8&#x02009;h (<bold>a</bold>), VAS at 12&#x02009;h (<bold>b</bold>), VAS at 24&#x02009;h (<bold>c</bold>), and VAS at 48&#x000a0;h (<bold>d</bold>) between the FICB group and the control group</p></caption><graphic xlink:href="13018_2018_1053_Fig4_HTML" id="MO4"/></fig></p></sec><sec id="Sec15"><title>Total morphine consumption</title><p id="Par28">A total of five studies reported total morphine consumption between the FICB group and the control group. We applied a random-effects model to analyze the results since there was a large heterogeneity between the included studies (<italic>I</italic><sup>2</sup>&#x000a0;=&#x02009;80.01%, <italic>P</italic>&#x02009;=&#x02009;0.000). The result shows that the FICB could significantly reduce total morphine consumption than the control group (WMD&#x02009;=&#x02009;&#x02212;&#x02009;23.35, 95% CI [&#x02212;&#x02009;40.53, &#x02212;&#x02009;6.18], <italic>P</italic>&#x02009;=&#x02009;0.008, Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><p>Forest plot for the comparison of total morphine consumption between the FICB group and the control group</p></caption><graphic xlink:href="13018_2018_1053_Fig5_HTML" id="MO5"/></fig></p></sec><sec id="Sec16"><title>Length of hospital stay</title><p id="Par29">A total of five studies reported the length of hospital stay between the FICB group and the control group. We applied a fixed-effects model to analyze the results since there was no heterogeneity between the included studies (<italic>I</italic><sup>2</sup>&#x000a0;=&#x02009;0.0%, <italic>P</italic>&#x02009;=&#x02009;0.796). The result shows that the FICB could significantly reduce the length of hospital stay than the control group (WMD&#x02009;=&#x02009;&#x02212;&#x02009;0.97, 95% CI [&#x02212;&#x02009;1.34, &#x02212;&#x02009;0.60], <italic>P</italic>&#x02009;=&#x02009;0.000, Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>).<fig id="Fig6"><label>Fig. 6</label><caption><p>Forest plot for the comparison of the length of hospital stay between the FICB group and the control group</p></caption><graphic xlink:href="13018_2018_1053_Fig6_HTML" id="MO6"/></fig></p></sec><sec id="Sec17"><title>The occurrence of nausea</title><p id="Par30">Six studies involving 179 patients were available for analysis of the occurrence of nausea. The FICB led to significantly less occurrence of nausea than the control group (RR&#x02009;=&#x02009;0.44, 95% CI [0.28 to 0.70], <italic>P</italic>&#x02009;=&#x02009;0.000; <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;0.0%, <italic>P</italic>&#x02009;=&#x02009;0.984, Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). Thus, we used a fixed-effects model to pool the relevant data.<fig id="Fig7"><label>Fig. 7</label><caption><p>Forest plot for the comparison of risk of nausea between the FICB group and the control group</p></caption><graphic xlink:href="13018_2018_1053_Fig7_HTML" id="MO7"/></fig></p></sec><sec id="Sec18"><title>The occurrence of fall</title><p id="Par31">Six studies provided data on the occurrence of fall. FICB was not associated with an increase of the occurrence of fall (RR&#x02009;=&#x02009;0.72, 95% CI [0.41 to 1.27], <italic>P</italic>&#x02009;=&#x02009;0.260 Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>). There was no heterogeneity between the included studies (<italic>I</italic><sup>2</sup>&#x02009;=&#x02009;0.0%, <italic>P</italic>&#x02009;=&#x02009;0.998); thus, we used a fixed-effects model to pool the occurrence of fall.<fig id="Fig8"><label>Fig. 8</label><caption><p>Forest plot for the comparison of the occurrence of fall between the FICB group and the control group</p></caption><graphic xlink:href="13018_2018_1053_Fig8_HTML" id="MO8"/></fig></p></sec><sec id="Sec19"><title>Publication bias, sensitivity analysis, and subgroup analysis</title><p id="Par32">The funnel plot (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>) and Begg&#x02019;s test (Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>) showed no publication bias in the included studies.<fig id="Fig9"><label>Fig. 9</label><caption><p>Funnel plot for the comparison of the VAS at 1&#x02013;8&#x02009;h between the FICB group and the control group</p></caption><graphic xlink:href="13018_2018_1053_Fig9_HTML" id="MO9"/></fig><fig id="Fig10"><label>Fig. 10</label><caption><p>Begg&#x02019;s test for the comparison of the VAS at 1&#x02013;8&#x02009;h between the FICB group and the control group</p></caption><graphic xlink:href="13018_2018_1053_Fig10_HTML" id="MO10"/></fig></p><p id="Par33">Sensitivity analysis was performed by excluding one trail in turn and recalculating the pooled WMD for the remaining trials, which found that none of the studies affected the result (Fig.&#x000a0;<xref rid="Fig11" ref-type="fig">11</xref>).<fig id="Fig11"><label>Fig. 11</label><caption><p>Sensitivity analysis of the VAS at 6&#x02013;8&#x02009;h between the FICB group and the control group</p></caption><graphic xlink:href="13018_2018_1053_Fig11_HTML" id="MO11"/></fig></p></sec></sec></sec><sec id="Sec20"><title>Discussion</title><sec id="Sec21"><title>Principal findings</title><p id="Par34">The pooled results indicate that, according to available evidence, THA patient administration with FICB was associated with a reduction of pain intensity up to 24&#x02009;h. What is more, FICB could significantly reduce total morphine consumption and the risk of nausea. However, there was no significant difference between the FICB and the control in the pain intensity at 48&#x02009;h and risk of fall.</p></sec><sec id="Sec22"><title>Relation to other systematic reviews</title><p id="Par35">There were two meta-analyses comparing FICB and placebo that have been published [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Zhang et al. [<xref ref-type="bibr" rid="CR21">21</xref>] found that FICB has a beneficial role in controlling pain in total hip and knee arthroplasties. Limitation of this meta-analysis was obvious; THA and total knee arthroplasty were two different surgeries, and thus, pain intensity was different. Fei et al. [<xref ref-type="bibr" rid="CR22">22</xref>] conducted a meta-analysis about FICB for pain control in lower limb surgery. Mixed different surgeries cause large clinical heterogeneity. In comparison, the current meta-analysis focused on THA only.</p></sec><sec id="Sec23"><title>Implications for clinical practice</title><p id="Par36">Our meta-analysis showed that the pain benefit existed in FICB compared with placebo. As we know, the femoral nerve and the lateral femoral cutaneous nerve innervate with the hip joint. FICB is injected through the iliac fascia cavity, which is constructed with the fascia as prezone and the iliopsoas as posterior. FICB could significantly block the femoral nerve, lateral femoral cutaneous nerve, and obturator nerve. Thus, FICB could decrease the pain intensity after THA. This beneficial effect was identified by previous trials. Besides, FICB is easy to administer, as it only requires ultrasound guidance. Steenberg et al. [<xref ref-type="bibr" rid="CR23">23</xref>] performed a systematic review and revealed that FICB is an effective and relatively safe supplement in the preoperative pain management of hip fracture patients. The main outcome was consistent with our conclusion. Considering the results of the current meta-analysis and published studies, we suggest the administration FICB for pain control for THA patients.</p><p id="Par37">Moreover, FICB could significantly decrease the morphine consumption and morphine-related complication (occurrence of nausea). McGraw-Tatum et al. [<xref ref-type="bibr" rid="CR24">24</xref>] identified that FICB required less overall total opioids than the control group. And FICB is a relatively safe anesthesia technique as the needle point is away from the femoral nerve, femoral artery, and femoral vein [<xref ref-type="bibr" rid="CR25">25</xref>].</p></sec><sec id="Sec24"><title>Limitations</title><p id="Par38">The present meta-analysis has some existing limitations that should be noted. First, only seven RCTs were included in this meta-analysis, and more high-quality studies are needed to confirm the above conclusions in the future. Second, patients were administered with different dose and regimes of FICB, which may lead to large heterogeneity. Third, the follow-up time in the included RCT was limited, and therefore, some adverse events may be underestimated. Fourth, a functional outcome is not performed due to the insufficiency of relevant data; future studies should observe the effects of FICB for hip function.</p></sec></sec><sec id="Sec25"><title>Conclusion</title><p id="Par39">Our meta-analysis suggested that FICB but not placebo significantly reduced postoperative pain for THA patients. The use of FICB significantly reduced morphine consumption and the risk of nausea. FICB is recommended as an adjunct to multimodal anesthesia for THA patients. Future studies should explore optimal strategies (including drug and volume) of FICB.</p></sec><sec sec-type="supplementary-material"><title>Additional file</title><sec id="Sec26"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13018_2018_1053_MOESM1_ESM.docx"><label>Additional file 1:</label><caption><p>Search strategies in PubMed (DOCX 14 kb)</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CI</term><def><p id="Par5">Confidence intervals</p></def></def-item><def-item><term>FICB</term><def><p id="Par6">Fascia iliaca compartment block</p></def></def-item><def-item><term>NSAIDs</term><def><p id="Par7">Non-steroidal antiinflammatory drugs</p></def></def-item><def-item><term>PRISMA</term><def><p id="Par8">Preferred Reporting Items for Systematic Reviews and Meta-Analyses</p></def></def-item><def-item><term>RCTs</term><def><p id="Par9">Randomized controlled trials</p></def></def-item><def-item><term>RR</term><def><p id="Par10">Risk ratio</p></def></def-item><def-item><term>THA</term><def><p id="Par11">Total hip arthroplasty</p></def></def-item><def-item><term>VAS</term><def><p id="Par12">Visual analog scale</p></def></def-item><def-item><term>WMD</term><def><p id="Par13">Weighted mean difference</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>We are grateful to all the patients and surgeons of the included studies.</p><sec id="FPar1"><title>Funding</title><p id="Par40">None.</p></sec><sec id="FPar2" sec-type="data-availability"><title>Availability of data and materials</title><p id="Par41">As a meta-analysis, there are no patient data sets.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>XYZ and JBM conceived of the design of this meta-analysis. XYZ and JBM performed the literature retrieval and article writing. XYZ and JBM contributed to the data extraction, and JBM revised the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p>Not applicable. This meta-analysis does not involve research on humans.</p></sec><sec id="FPar4"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar5"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="FPar6"><title>Publisher&#x02019;s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>W</given-names></name></person-group><article-title>Comparison of intravenous and oral acetaminophen for pain control after total knee and hip arthroplasty: a systematic review and meta-analysis</article-title><source>Medicine</source><year>2018</year><volume>97</volume><issue>6</issue><fpage>e9751</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000009751</pub-id><pub-id pub-id-type="pmid">29419667</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Gong</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xiang</surname><given-names>Z</given-names></name></person-group><article-title>Effect of methylprednisolone on pain management in total knee or hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials</article-title><source>Clin J Pain</source><year>2018</year><volume>34</volume><issue>10</issue><fpage>967</fpage><lpage>974</lpage><?supplied-pmid 29595528?><pub-id pub-id-type="pmid">29595528</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindestrand</surname><given-names>AG</given-names></name><name><surname>Christiansen</surname><given-names>ML</given-names></name><name><surname>Jantzen</surname><given-names>C</given-names></name><name><surname>van der Mark</surname><given-names>S</given-names></name><name><surname>Andersen</surname><given-names>SE</given-names></name></person-group><article-title>Opioids in hip fracture patients: an analysis of mortality and post hospital opioid use</article-title><source>Injury</source><year>2015</year><volume>46</volume><issue>7</issue><fpage>1341</fpage><lpage>1345</lpage><pub-id pub-id-type="doi">10.1016/j.injury.2015.04.016</pub-id><pub-id pub-id-type="pmid">25952252</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aghayev</surname><given-names>E</given-names></name><name><surname>Teuscher</surname><given-names>R</given-names></name><name><surname>Neukamp</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>EJ</given-names></name><name><surname>Melloh</surname><given-names>M</given-names></name><name><surname>Eggli</surname><given-names>S</given-names></name><name><surname>Roder</surname><given-names>C</given-names></name></person-group><article-title>The course of radiographic loosening, pain and functional outcome around the first revision of a total hip arthroplasty</article-title><source>BMC Musculoskelet Disord</source><year>2013</year><volume>14</volume><fpage>167</fpage><pub-id pub-id-type="doi">10.1186/1471-2474-14-167</pub-id><pub-id pub-id-type="pmid">23672339</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guay</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>RL</given-names></name><name><surname>Kopp</surname><given-names>S</given-names></name></person-group><article-title>Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults</article-title><source>Cochrane Database Syst Rev</source><year>2017</year><volume>10</volume><fpage>Cd011608</fpage><?supplied-pmid 29087547?><pub-id pub-id-type="pmid">29087547</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eyi</surname><given-names>YE</given-names></name><name><surname>Arziman</surname><given-names>I</given-names></name><name><surname>Kaldirim</surname><given-names>U</given-names></name><name><surname>Tuncer</surname><given-names>SK</given-names></name></person-group><article-title>Fascia iliaca compartment block in the reduction of dislocation of total hip arthroplasty</article-title><source>Am J Emerg Med</source><year>2014</year><volume>32</volume><issue>9</issue><fpage>1139</fpage><pub-id pub-id-type="doi">10.1016/j.ajem.2014.06.007</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desmet</surname><given-names>M</given-names></name><name><surname>Vermeylen</surname><given-names>K</given-names></name><name><surname>Van Herreweghe</surname><given-names>I</given-names></name><name><surname>Carlier</surname><given-names>L</given-names></name><name><surname>Soetens</surname><given-names>F</given-names></name><name><surname>Lambrecht</surname><given-names>S</given-names></name><name><surname>Croes</surname><given-names>K</given-names></name><name><surname>Pottel</surname><given-names>H</given-names></name><name><surname>Van de Velde</surname><given-names>M</given-names></name></person-group><article-title>A longitudinal supra-inguinal fascia iliaca compartment block reduces morphine consumption after total hip arthroplasty</article-title><source>Reg Anesth Pain Med</source><year>2017</year><volume>42</volume><issue>3</issue><fpage>327</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1097/AAP.0000000000000543</pub-id><pub-id pub-id-type="pmid">28059869</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>CR</given-names><suffix>Jr</suffix></name><name><surname>Fahs</surname><given-names>AM</given-names></name><name><surname>Kurdziel</surname><given-names>MD</given-names></name><name><surname>Koueiter</surname><given-names>DM</given-names></name><name><surname>Fayne</surname><given-names>RJ</given-names></name><name><surname>Verner</surname><given-names>JJ</given-names></name></person-group><article-title>Intraoperative psoas compartment block vs preoperative fascia iliaca block for pain control after direct anterior total hip arthroplasty: a randomized controlled trial</article-title><source>J Arthroplast</source><year>2018</year><volume>33</volume><issue>6</issue><fpage>1770</fpage><lpage>1774</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2018.01.010</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aprato</surname><given-names>A</given-names></name><name><surname>Audisio</surname><given-names>A</given-names></name><name><surname>Santoro</surname><given-names>A</given-names></name><name><surname>Grosso</surname><given-names>E</given-names></name><name><surname>Devivo</surname><given-names>S</given-names></name><name><surname>Berardino</surname><given-names>M</given-names></name><name><surname>Masse</surname><given-names>A</given-names></name></person-group><article-title>Fascia-iliaca compartment block vs intra-articular hip injection for preoperative pain management in intracapsular hip fractures: a blind, randomized, controlled trial</article-title><source>Injury</source><year>2018</year><volume>49</volume><issue>12</issue><fpage>2203</fpage><lpage>2208</lpage><pub-id pub-id-type="doi">10.1016/j.injury.2018.09.042</pub-id><pub-id pub-id-type="pmid">30274756</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knobloch</surname><given-names>K</given-names></name><name><surname>Yoon</surname><given-names>U</given-names></name><name><surname>Vogt</surname><given-names>PM</given-names></name></person-group><article-title>Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and publication bias</article-title><source>J Craniomaxillofac Surg</source><year>2011</year><volume>39</volume><issue>2</issue><fpage>91</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.jcms.2010.11.001</pub-id><pub-id pub-id-type="pmid">21145753</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DerSimonian</surname><given-names>R</given-names></name><name><surname>Laird</surname><given-names>N</given-names></name></person-group><article-title>Meta-analysis in clinical trials</article-title><source>Control Clin Trials</source><year>1986</year><volume>7</volume><issue>3</issue><fpage>177</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/0197-2456(86)90046-2</pub-id><pub-id pub-id-type="pmid">3802833</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>JP</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name><name><surname>Deeks</surname><given-names>JJ</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><article-title>Measuring inconsistency in meta-analyses</article-title><source>BMJ</source><year>2003</year><volume>327</volume><issue>7414</issue><fpage>557</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1136/bmj.327.7414.557</pub-id><pub-id pub-id-type="pmid">12958120</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Minder</surname><given-names>C</given-names></name></person-group><article-title>Bias in meta-analysis detected by a simple, graphical test</article-title><source>BMJ</source><year>1997</year><volume>315</volume><issue>7109</issue><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1136/bmj.315.7109.629</pub-id><pub-id pub-id-type="pmid">9310563</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badica</surname><given-names>IC</given-names></name><name><surname>Pavelescu</surname><given-names>D</given-names></name><name><surname>Badica</surname><given-names>L</given-names></name><name><surname>Barbilian</surname><given-names>R</given-names></name><name><surname>Grintescu</surname><given-names>I</given-names></name></person-group><article-title>The efficacy of fascia iliaca compartment block (FICB) for postoperative analgesia after hip arthroplasty (HA)</article-title><source>Reg Anes Pain Med</source><year>2010</year><volume>35</volume><issue>5</issue><fpage>E80</fpage></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shariat</surname><given-names>AN</given-names></name><name><surname>Hadzic</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Shastri</surname><given-names>U</given-names></name><name><surname>Kwofie</surname><given-names>K</given-names></name><name><surname>Gandhi</surname><given-names>K</given-names></name><name><surname>McCally</surname><given-names>CM</given-names></name><name><surname>Gratenstein</surname><given-names>K</given-names></name><name><surname>Vandepitte</surname><given-names>C</given-names></name><name><surname>Gadsden</surname><given-names>J</given-names></name><etal/></person-group><article-title>Fascia lliaca block for analgesia after hip arthroplasty: a randomized double-blind, placebo-controlled trial</article-title><source>Reg Anesth Pain Med</source><year>2013</year><volume>38</volume><issue>3</issue><fpage>201</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1097/AAP.0b013e31828a3c7c</pub-id><pub-id pub-id-type="pmid">23558369</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>M</given-names></name><name><surname>Harrison</surname><given-names>G</given-names></name><name><surname>McGrail</surname><given-names>M</given-names></name></person-group><article-title>A modified fascia iliaca compartment block has significant morphine-sparing effect after total hip arthroplasty</article-title><source>Anaesth Intensive Care</source><year>2007</year><volume>35</volume><issue>6</issue><fpage>949</fpage><lpage>952</lpage><?supplied-pmid 18084988?><pub-id pub-id-type="pmid">18084988</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bang</surname><given-names>S</given-names></name><name><surname>Chung</surname><given-names>J</given-names></name><name><surname>Jeong</surname><given-names>J</given-names></name><name><surname>Bak</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name></person-group><article-title>Efficacy of ultrasound-guided fascia iliaca compartment block after hip hemiarthroplasty: a prospective, randomized trial</article-title><source>Medicine</source><year>2016</year><volume>95</volume><issue>39</issue><fpage>e5018</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000005018</pub-id><pub-id pub-id-type="pmid">27684871</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goitia Arrola</surname><given-names>L</given-names></name><name><surname>Telletxea</surname><given-names>S</given-names></name><name><surname>Martinez Bourio</surname><given-names>R</given-names></name><name><surname>Arizaga Maguregui</surname><given-names>A</given-names></name><name><surname>Aguirre Larracoechea</surname><given-names>U</given-names></name></person-group><article-title>Fascia iliaca compartment block for analgesia following total hip replacement surgery</article-title><source>Rev Esp Anestesiol Reanim</source><year>2009</year><volume>56</volume><issue>6</issue><fpage>343</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/S0034-9356(09)70406-2</pub-id><pub-id pub-id-type="pmid">19725341</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deniz</surname><given-names>S</given-names></name><name><surname>Atim</surname><given-names>A</given-names></name><name><surname>Kurklu</surname><given-names>M</given-names></name><name><surname>Cayci</surname><given-names>T</given-names></name><name><surname>Kurt</surname><given-names>E</given-names></name></person-group><article-title>Comparison of the postoperative analgesic efficacy of an ultrasound-guided fascia iliaca compartment block versus 3 in 1 block in hip prosthesis surgery</article-title><source>Agri</source><year>2014</year><volume>26</volume><issue>4</issue><fpage>151</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.5505/agri.2014.76993</pub-id><pub-id pub-id-type="pmid">25551810</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name></person-group><article-title>The efficacy of ultrasound-guided continuous iliac fascia space block for postoperative analge-sia in elderly patients undergoing total hip replacement</article-title><source>Prac J Clin Med</source><year>2016</year><volume>13</volume><issue>2</issue><fpage>114</fpage><lpage>117</lpage></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>The efficiency and safety of fascia iliaca block for pain control after total joint arthroplasty: a meta-analysis</article-title><source>Medicine</source><year>2017</year><volume>96</volume><issue>15</issue><fpage>e6592</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000006592</pub-id><pub-id pub-id-type="pmid">28403096</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fei</surname><given-names>D</given-names></name><name><surname>Ma</surname><given-names>LP</given-names></name><name><surname>Yuan</surname><given-names>HP</given-names></name><name><surname>Zhao</surname><given-names>DX</given-names></name></person-group><article-title>Comparison of femoral nerve block and fascia iliaca block for pain management in total hip arthroplasty: a meta-analysis</article-title><source>Int J Surg</source><year>2017</year><volume>46</volume><fpage>11</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.ijsu.2017.08.008</pub-id><pub-id pub-id-type="pmid">28801189</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steenberg</surname><given-names>J</given-names></name><name><surname>Moller</surname><given-names>AM</given-names></name></person-group><article-title>Systematic review of the effects of fascia iliaca compartment block on hip fracture patients before operation</article-title><source>Br J Anaesth</source><year>2018</year><volume>120</volume><issue>6</issue><fpage>1368</fpage><lpage>1380</lpage><pub-id pub-id-type="doi">10.1016/j.bja.2017.12.042</pub-id><pub-id pub-id-type="pmid">29793602</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGraw-Tatum</surname><given-names>MA</given-names></name><name><surname>Groover</surname><given-names>MT</given-names></name><name><surname>George</surname><given-names>NE</given-names></name><name><surname>Urse</surname><given-names>JS</given-names></name><name><surname>Heh</surname><given-names>V</given-names></name></person-group><article-title>A prospective, randomized trial comparing liposomal bupivacaine vs fascia iliaca compartment block for postoperative pain control in total hip arthroplasty</article-title><source>J Arthroplast</source><year>2017</year><volume>32</volume><issue>7</issue><fpage>2181</fpage><lpage>2185</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2017.02.019</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostafa</surname><given-names>SF</given-names></name><name><surname>Eid</surname><given-names>GM</given-names></name><name><surname>Elkalla</surname><given-names>RS</given-names></name></person-group><article-title>Patient-controlled fascia iliaca compartment block versus fentanyl patient-controlled intravenous analgesia in patients undergoing femur fracture surgery &#x02606;</article-title><source>Egypt J Anal Chem</source><year>2018</year><volume>34</volume><issue>1</issue><fpage>9</fpage><lpage>13</lpage></element-citation></ref></ref-list></back></article>